O-159 A prospective randomized phase III, double-blind, placebo-controlled study of thalidomide in extended-disease (ED) SCLC patients after response to chemotherapy (CT)
LUNG CANCER（2005）
Key words
thalidomide,chemotherapy,sclc patients,double-blind,placebo-controlled,extended-disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined